tiprankstipranks
JCR Pharmaceuticals Co., Ltd. (JP:4552)
:4552
Japanese Market
4552
JCR Pharmaceuticals Co., Ltd.
RESEARCH TOOLSreports
Want to see JP:4552 full AI Analyst Report?

JCR Pharmaceuticals Co., Ltd. (4552) Financial Statements

1 Followers

JCR Pharmaceuticals Co., Ltd. Financial Overview

JCR Pharmaceuticals Co., Ltd.'s market cap is currently ¥61.01B. The company's EPS TTM is ¥-45.01; its P/E ratio is 31.79; and it has a dividend yield of 2.71%. JCR Pharmaceuticals Co., Ltd. is scheduled to report earnings on May 13, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 26Mar 25Mar 24Mar 23
Income Statement
Total Revenue¥ 33.07B¥ 40.32B¥ 42.87B¥ 34.34B¥ 51.08B
Gross Profit¥ 21.55B¥ 30.06B¥ 31.25B¥ 25.46B¥ 40.62B
Operating Income¥ -6.84B¥ 431.00M¥ 7.53B¥ 4.98B¥ 19.93B
EBITDA¥ -3.47B¥ 2.99B¥ 10.73B¥ 6.97B¥ 21.88B
Net Income¥ -4.76B¥ 2.18B¥ 5.51B¥ 3.77B¥ 14.51B
Balance Sheet
Cash & Short-Term Investments¥ 13.20B¥ 14.01B¥ 18.76B¥ 13.28B¥ 30.98B
Total Assets¥ 105.45B¥ 109.24B¥ 102.67B¥ 95.36B¥ 97.48B
Total Debt¥ 38.28B¥ 53.89B¥ 23.43B¥ 22.92B¥ 18.16B
Net Debt¥ 25.09B¥ 39.88B¥ 4.67B¥ 9.64B¥ -12.57B
Total Liabilities¥ 58.01B¥ 61.88B¥ 46.19B¥ 42.95B¥ 46.39B
Stockholders' Equity¥ 47.04B¥ 46.94B¥ 56.18B¥ 52.16B¥ 50.88B
Cash Flow
Free Cash Flow¥ -15.37B¥ -11.56B¥ 7.79B¥ -13.15B¥ -2.04B
Operating Cash Flow¥ -5.49B¥ -135.00M¥ 9.31B¥ -5.50B¥ 9.29B
Investing Cash Flow¥ -9.87B¥ -12.50B¥ -2.69B¥ -15.00B¥ -3.25B
Financing Cash Flow¥ 9.74B¥ 13.30B¥ -2.03B¥ 1.95B¥ -2.18B
Currency in JPY

JCR Pharmaceuticals Co., Ltd. Earnings and Revenue History

Income Statement >

JCR Pharmaceuticals Co., Ltd. Debt to Assets

Balance Sheet >

JCR Pharmaceuticals Co., Ltd. Cash Flow

Cash Flow >

JCR Pharmaceuticals Co., Ltd. Forecast EPS vs Actual EPS

Earnings >